A detailed history of Waldron Private Wealth LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Waldron Private Wealth LLC holds 22,686 shares of ABT stock, worth $2.58 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
22,686
Previous 22,549 0.61%
Holding current value
$2.58 Million
Previous $2.34 Million 10.37%
% of portfolio
0.11%
Previous 0.11%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$100.07 - $118.13 $13,709 - $16,183
137 Added 0.61%
22,686 $2.59 Million
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $23,470 - $26,198
233 Added 1.04%
22,549 $2.34 Million
Q1 2024

May 09, 2024

SELL
$109.52 - $120.96 $39,974 - $44,150
-365 Reduced 1.61%
22,316 $2.54 Million
Q4 2023

Aug 29, 2024

BUY
$90.19 - $110.4 $108,228 - $132,480
1,200 Added 5.59%
22,681 $2.5 Million
Q4 2023

Jan 30, 2024

BUY
$90.19 - $110.4 $108,228 - $132,480
1,200 Added 5.59%
22,681 $2.5 Million
Q3 2023

Aug 29, 2024

SELL
$95.53 - $114.62 $120,367 - $144,421
-1,260 Reduced 5.54%
21,481 $2.08 Million
Q3 2023

Oct 26, 2023

SELL
$95.53 - $114.62 $120,367 - $144,421
-1,260 Reduced 5.54%
21,481 $2.08 Million
Q2 2023

Aug 29, 2024

SELL
$100.78 - $112.29 $7,457 - $8,309
-74 Reduced 0.32%
22,741 $2.48 Million
Q2 2023

Aug 07, 2023

SELL
$100.78 - $112.29 $7,457 - $8,309
-74 Reduced 0.32%
22,741 $2.48 Million
Q1 2023

Aug 29, 2024

BUY
$96.86 - $114.01 $25,764 - $30,326
266 Added 1.18%
22,815 $2.31 Million
Q1 2023

May 02, 2023

BUY
$96.86 - $114.01 $113,326 - $133,391
1,170 Added 5.41%
22,815 $2.31 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $119,305 - $138,132
-1,233 Reduced 5.39%
21,645 $2.09 Million
Q2 2022

Aug 03, 2022

BUY
$102.07 - $123.37 $123,198 - $148,907
1,207 Added 5.57%
22,878 $2.49 Million
Q1 2022

May 04, 2022

BUY
$114.02 - $139.04 $66,131 - $80,643
580 Added 2.75%
21,671 $2.57 Million
Q4 2021

Feb 02, 2022

BUY
$115.53 - $141.46 $70,126 - $85,866
607 Added 2.96%
21,091 $2.97 Million
Q3 2021

Nov 02, 2021

BUY
$116.66 - $129.06 $422,309 - $467,197
3,620 Added 21.47%
20,484 $2.42 Million
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $100,817 - $118,677
-953 Reduced 5.35%
16,864 $1.96 Million
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $54,202 - $63,858
498 Added 2.88%
17,817 $2.14 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $60,270 - $65,677
-574 Reduced 3.21%
17,319 $1.9 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $76,427 - $92,815
834 Added 4.89%
17,893 $1.95 Million
Q2 2020

Aug 11, 2020

BUY
$76.57 - $98.0 $32,159 - $41,160
420 Added 2.52%
17,059 $1.56 Million
Q1 2020

May 05, 2020

BUY
$62.82 - $91.86 $14,260 - $20,852
227 Added 1.38%
16,639 $1.31 Million
Q3 2019

Nov 06, 2019

SELL
$81.84 - $88.74 $81,185 - $88,030
-992 Reduced 5.7%
16,412 $1.37 Million
Q2 2019

Jul 31, 2019

SELL
$72.88 - $85.0 $45,695 - $53,295
-627 Reduced 3.48%
17,404 $1.46 Million
Q1 2019

May 01, 2019

BUY
$66.22 - $80.06 $246,073 - $297,502
3,716 Added 25.96%
18,031 $1.44 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $264,403 - $299,530
4,033 Added 39.22%
14,315 $1.04 Million
Q3 2018

Nov 20, 2018

BUY
$60.81 - $73.36 $198,301 - $239,226
3,261 Added 46.45%
10,282 $754,000
Q2 2018

Aug 09, 2018

BUY
$57.57 - $63.54 $7,484 - $8,260
130 Added 1.89%
7,021 $428,000
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $25,659 - $29,010
-456 Reduced 6.21%
6,891 $412,000
Q4 2017

Jan 26, 2018

BUY
$53.68 - $57.47 $24,478 - $26,206
456 Added 6.62%
7,347 $419,000
Q3 2017

Nov 08, 2017

BUY
$48.06 - $53.64 $2,403 - $2,682
50 Added 0.73%
6,891 $367,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,841
6,841 $332,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Waldron Private Wealth LLC Portfolio

Follow Waldron Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waldron Private Wealth LLC with notifications on news.